The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome Type 3

Por um escritor misterioso

Descrição

IMR Press is a leading publisher of open access peer-reviewed biomedical and life sciences journals. We aim to facilitate the dissemination of high-quality research in the area of biomedical science. With a long tradition and wide readership, IMR Press is dedicated to making positive contributions to academics, corporate libraries as well as to readers and authors. All the editors in IMR Press will provide the best service for researchers, allowing them to have a easy and smooth publication experience and helping maximize the impact and visibility of their research.
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome: Pathophysiology as a key to the therapeutic
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cureus, Cardiorenal Syndrome: A Literature Review
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
The role of SGLT2 inhibitors in type 2 diabetes mellitus with
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Acute Cardiorenal Syndrome: Epidemiology, Pathophysiology
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome: Multi‐organ dysfunction involving the heart
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Figure 5 from Cardiorenal Syndrome Revisited
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
The cardio-renal-metabolic connection: a review of the evidence
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Frontiers A comprehensive review of acute cardio-renal syndrome
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardio renal syndrome - Cancer Therapy Advisor
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Urine peptidome analysis in cardiorenal syndrome reflects
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome classification system
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Cardiorenal syndrome prof.osama el-shahat
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
Biomolecules, Free Full-Text
The Molecular Mechanism and Therapeutic Strategy of Cardiorenal Syndrome  Type 3
A Clinically Relevant Functional Model of Type-2 Cardio-Renal
de por adulto (o preço varia de acordo com o tamanho do grupo)